| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| breast cancer screening guidelines uspstf | 1.73 | 0.4 | 6804 | 26 | 41 |
| breast | 1.28 | 0.6 | 6074 | 93 | 6 |
| cancer | 1.34 | 0.6 | 3414 | 65 | 6 |
| screening | 0.46 | 0.4 | 3373 | 19 | 9 |
| guidelines | 1.54 | 0.1 | 8611 | 56 | 10 |
| uspstf | 0.7 | 1 | 3521 | 35 | 6 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| breast cancer screening guidelines uspstf | 1.11 | 0.8 | 9023 | 75 |
| uspstf guidelines breast cancer | 1.96 | 0.3 | 7710 | 65 |
| breast cancer screening age uspstf | 0.68 | 0.1 | 3810 | 33 |
| uspstf breast cancer screening 2021 | 1.12 | 0.9 | 8944 | 21 |
| uspstf guidelines cancer screening | 0.94 | 0.7 | 5729 | 1 |
| uspstf breast cancer screen | 0.02 | 0.5 | 7947 | 17 |
| uspstf breat cancer screening | 0.79 | 0.1 | 1859 | 80 |
| uspstf guidelines clinical breast exam | 0.61 | 0.3 | 2717 | 77 |
| uspstf guidelines breast cancer screening | 0.46 | 0.1 | 8458 | 11 |
Breast cancer. Women ages 40 to 44 should have the choice to start annual breast cancer screening with mammograms (x-rays of the breast) if they wish to do so. Women age 45 to 54 should get mammograms every year. Women 55 and older should switch to mammograms every 2 years, or can continue yearly screening. Screening should continue as long as ...
What are the recommendations for breast cancer screening?Screening Guidelines for Women at Average Breast Cancer Risk. MSK doctors recommend the following for women at average risk* of breast cancer: Women between the ages of 25 and 40 should have an annual clinical breast examination. Women 40 and older should have an annual mammogram in addition to an annual clinical breast examination.
What are the ACR guidelines for breast cancer screening?The ACR currently recommends annual mammographic screening beginning at age 40 for women at average risk for breast cancer. Women with additional risk factors placing them at higher-than-average risk for developing breast cancer need further consideration for earlier and/or more intensive screening.
